T80.419 Rh incompatibility with hemolytic transfusion reaction, unspecified

Name of the Condition

• Rh incompatibility with hemolytic transfusion reaction, unspecified.

Summary

This condition describes an immune-mediated hemolytic reaction resulting from Rh incompatibility during a transfusion. It occurs when Rh-negative individuals receive Rh-positive blood or blood products, leading to the destruction of red blood cells (hemolysis). The recipient’s immune system recognizes Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The term "unspecified" indicates the reaction’s timing or severity is not further defined.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources. The unspecified nature of the reaction means the timing (acute or delayed) is not specified.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests may show hemolysis, elevated bilirubin, or positive direct antiglobulin test (DAT). The unspecified nature of the reaction means timing is not a diagnostic criterion.

Treatment Options

Treatment focuses on stopping the transfusion, managing hemolysis (e.g., fluids, diuretics), and addressing complications like renal failure or shock. Supportive care, including monitoring vital signs and laboratory values, is standard. Specific interventions depend on the reaction’s severity.

Prognosis and Follow-Up

Prognosis varies based on the reaction’s severity and promptness of treatment. Mild cases may resolve with supportive care, while severe reactions can lead to organ damage or death. Follow-up includes monitoring for delayed complications and ensuring future transfusions use Rh-compatible blood.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or hypotension
• Severe anemia requiring additional transfusions
• Long-term organ damage from hemolysis

Lifestyle & Prevention

Prevention involves rigorous blood typing and crossmatching before transfusions. Rh-negative individuals should receive Rh-negative blood products when possible. Healthcare providers should verify blood product compatibility and document transfusion reactions promptly.

When to Seek Professional Help

Seek immediate medical attention if symptoms like fever, chills, jaundice, or shortness of breath occur during or after a transfusion. These may indicate a hemolytic reaction requiring urgent intervention.

Tips for Medical Coders

Code T80.419 is used for Rh incompatibility with hemolytic transfusion reaction when the timing (acute or delayed) is not specified. Document the transfusion context, clinical findings (e.g., hemolysis, jaundice), and any relevant laboratory results to support coding. Ensure the unspecified nature of the reaction is clearly documented, as this distinguishes it from acute or delayed variants.